AffiliationInnovative & Intensified Disease Management, Neglected Tropical Diseases, WHO, Geneva, Switzerland. email@example.com
MetadataShow full item record
AbstractChagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.
- [Chagas disease].
- Authors: Develoux M, Lescure FX, Le Loup G, Pialoux G
- Issue date: 2009 Aug
- Current drug therapy and pharmaceutical challenges for Chagas disease.
- Authors: Bermudez J, Davies C, Simonazzi A, Real JP, Palma S
- Issue date: 2016 Apr
- Perspectives in Chagas disease treatment.
- Authors: Oliveira GB, Avezum Á, Cordeiro Mattos AJ
- Issue date: 2015 Sep
- Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
- Authors: Murcia L, Carrilero B, Albajar Viñas P, Segovia M
- Issue date: 2012 Mar
- Etiological treatment for infection by Trypanosoma cruzi.
- Authors: Amato Neto V
- Issue date: 1999